Clinical significance of monitoring KRAS in tissue and plasma of pancreatic cancer patients

被引：0
|
作者：
Watanabe, Fumiaki
Suzuki, Koichi
Endo, Yuhei
Ishikawa, Hideki
Kakizawa, Nao
Noda, Hiroshi
Rikiyama, Toshiki
机构：
[1] Jichi Med Univ, Saitama, Japan
[2] Jichi Med Univ, Saitama Med Ctr, Saitama, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 04期
关键词：
D O I：
10.1200/JCO.2019.37.4_suppl.254
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
254
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Clinical Significance of Germline Cancer Predisposing Variants in Unselected Patients with Pancreatic Adenocarcinoma
    Fountzilas, Elena
    Eliades, Alexia
    Koliou, Georgia-Angeliki
    Achilleos, Achilleas
    Loizides, Charalambos
    Tsangaras, Kyriakos
    Pectasides, Dimitrios
    Sgouros, Joseph
    Papakostas, Pavlos
    Rallis, Grigorios
    Psyrri, Amanda
    Papadimitriou, Christos
    Oikonomopoulos, Georgios
    Ferentinos, Konstantinos
    Koumarianou, Anna
    Zarkavelis, George
    Dervenis, Christos
    Aravantinos, Gerasimos
    Bafaloukos, Dimitrios
    Kosmidis, Paris
    Papaxoinis, George
    Theochari, Maria
    Varthalitis, Ioannis
    Kentepozidis, Nikolaos
    Rigakos, Georgios
    Saridaki, Zacharenia
    Nikolaidi, Adamantia
    Christopoulou, Athina
    Fostira, Florentia
    Samantas, Epaminontas
    Kypri, Elena
    Ioannides, Marios
    Koumbaris, George
    Fountzilas, George
    Patsalis, Philippos C.
    CANCERS, 2021, 13 (02) : 1 - 13
  • [42] Targeting KRAS in Pancreatic Cancer
    Cowzer, Darren
    Zameer, Mohammed
    Conroy, Michael
    Kolch, Walter
    Duffy, Austin G.
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (11):
  • [43] Targeting KRAS in pancreatic cancer
    Stickler, Sandra
    Rath, Barbara
    Hamilton, Gerhard
    ONCOLOGY RESEARCH, 2024, 32 (05) : 799 - 805
  • [44] KRAS mutation in pancreatic cancer
    Luo, Ji
    SEMINARS IN ONCOLOGY, 2021, 48 (01) : 10 - 18
  • [45] Clinical Significance of Matrix Metalloproteinases in Blood Plasma of Patients with Gastric Cancer
    N. E. Kushlinskii
    E. S. Gershtein
    A. A. Ivannikov
    M. M. Davydov
    V. L. Chang
    N. A. Ognerubov
    I. S. Stilidi
    Bulletin of Experimental Biology and Medicine, 2019, 166 : 373 - 376
  • [46] Clinical significance of plasma fibrinogen level in patients with prostate cancer.
    Ma, Xiao-Kun
    Wen, Jing-Yun
    Chen, Zhan-Hong
    Lin, Qu
    Li, Xing
    Dong, Min
    Wei, Li
    Chen, Jie
    Wang, Tian Tian
    Ruan, Dan-Yun
    Lin, Ze-Xiao
    Wan, XiangBo
    Wu, Xiang-Yuan
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [47] Clinical Significance of Matrix Metalloproteinases in Blood Plasma of Patients with Gastric Cancer
    Kushlinskii, N. E.
    Gershtein, E. S.
    Ivannikov, A. A.
    Davydov, M. M.
    Chang, V. L.
    Ognerubov, N. A.
    Stilidi, I. S.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2019, 166 (03) : 373 - 376
  • [48] KRAS Mutations and Their Correlation With Survival of Patients With Advanced Pancreatic Cancer
    Bournet, Barbara
    Muscari, Fabrice
    Guimbaud, Rosine
    Cordelier, Pierre
    Buscail, Louis
    PANCREAS, 2013, 42 (03) : 543 - 544
  • [49] Incidence of Thromboembolism and Significance of Plasma D-Dimer Levels in Pancreatic Cancer Patients
    Harada, T.
    Inoue, H.
    Yamada, R.
    Takei, Y.
    PANCREAS, 2014, 43 (08) : 1363 - 1363
  • [50] Mutant KRAS Circulating Tumor DNA Is an Accurate Tool for Pancreatic Cancer Monitoring
    Perets, Ruth
    Greenberg, Orli
    Shentzer, Talia
    Semenisty, Valeria
    Epelbaum, Ron
    Bick, Tova
    Sarji, Shada
    Ben-Izhak, Ofer
    Sabo, Edmond
    Hershkovitz, Dov
    ONCOLOGIST, 2018, 23 (05): : 566 - 572
12345